Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Clorox Co tiene un precio objetivo de consenso de $136.5 basado en las calificaciones de 20 analistas. El máximo es $170, emitido por TD Cowen el noviembre 6, 2024. El mínimo es $112, emitido por Barclays el octubre 1, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Citigroup, Morgan Stanley y Wells Fargo el noviembre 4, 2025, respectivamente. Con un precio objetivo promedio de $120.67 entre Citigroup, Morgan Stanley y Wells Fargo, hay una 18.88% upside implícita para Clorox Co según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/04/2025 | 18.23% | Citigroup | $130 → $120 | Maintains | Neutral | |||
11/04/2025 | 23.15% | Morgan Stanley | $137 → $125 | Maintains | Equal-Weight | |||
11/04/2025 | 15.27% | Wells Fargo | $125 → $117 | Maintains | Equal-Weight | |||
11/04/2025 | 18.23% | JP Morgan | $127 → $120 | Maintains | Neutral | |||
10/10/2025 | 25.12% | JP Morgan | $135 → $127 | Maintains | Neutral | |||
10/09/2025 | 28.08% | Citigroup | $135 → $130 | Maintains | Neutral | |||
10/08/2025 | 23.15% | B of A Securities | $135 → $125 | Maintains | Neutral | |||
10/08/2025 | 26.11% | UBS | $134 → $128 | Maintains | Neutral | |||
10/01/2025 | 10.34% | Barclays | $118 → $112 | Maintains | Underweight | |||
09/25/2025 | 23.15% | Wells Fargo | $130 → $125 | Maintains | Equal-Weight | |||
09/08/2025 | 33% | JP Morgan | $133 → $135 | Maintains | Neutral | |||
09/05/2025 | 28.08% | Wells Fargo | $138 → $130 | Maintains | Equal-Weight | |||
08/01/2025 | 34.98% | Morgan Stanley | $150 → $137 | Maintains | Equal-Weight | |||
08/01/2025 | 35.96% | Wells Fargo | $135 → $138 | Maintains | Equal-Weight | |||
07/25/2025 | 37.93% | JP Morgan | $144 → $140 | Maintains | Neutral | |||
07/17/2025 | 32.02% | UBS | $150 → $134 | Maintains | Neutral | |||
07/15/2025 | 33% | Citigroup | $140 → $135 | Maintains | Neutral | |||
07/15/2025 | 17.24% | Barclays | $129 → $119 | Maintains | Underweight | |||
07/09/2025 | 33% | Wells Fargo | $142 → $135 | Maintains | Equal-Weight | |||
06/26/2025 | 42.86% | Jefferies | $167 → $145 | Maintains | Buy | |||
05/07/2025 | 27.09% | Barclays | $134 → $129 | Maintains | Underweight | |||
05/06/2025 | 47.78% | Morgan Stanley | $165 → $150 | Maintains | Equal-Weight | |||
05/06/2025 | 39.9% | Wells Fargo | $145 → $142 | Maintains | Equal-Weight | |||
05/06/2025 | 41.87% | JP Morgan | $151 → $144 | Maintains | Neutral | |||
04/17/2025 | 51.72% | UBS | $176 → $154 | Maintains | Neutral | |||
04/16/2025 | 42.86% | Wells Fargo | $155 → $145 | Maintains | Equal-Weight | |||
04/14/2025 | 47.78% | Citigroup | $165 → $150 | Maintains | Neutral | |||
04/11/2025 | 32.02% | Barclays | $139 → $134 | Maintains | Underweight | |||
04/11/2025 | 48.77% | JP Morgan | $173 → $151 | Maintains | Neutral | |||
04/02/2025 | 52.71% | Wells Fargo | $161 → $155 | Maintains | Equal-Weight | |||
03/27/2025 | 36.95% | Barclays | $140 → $139 | Maintains | Underweight | |||
02/05/2025 | 37.93% | Barclays | $130 → $140 | Maintains | Underweight | |||
02/05/2025 | 66.5% | DA Davidson | $171 → $169 | Maintains | Neutral | |||
02/04/2025 | 70.44% | JP Morgan | $171 → $173 | Maintains | Neutral | |||
02/04/2025 | 58.62% | Wells Fargo | $157 → $161 | Maintains | Equal-Weight | |||
01/30/2025 | 47.78% | RBC Capital | $150 → $150 | Reiterates | Sector Perform → Sector Perform | |||
01/17/2025 | 28.08% | Barclays | $139 → $130 | Maintains | Underweight | |||
01/16/2025 | 68.47% | JP Morgan | $167 → $171 | Maintains | Neutral | |||
01/07/2025 | 54.68% | Wells Fargo | $155 → $157 | Upgrade | Underweight → Equal-Weight | |||
11/06/2024 | 67.49% | TD Cowen | $155 → $170 | Upgrade | Sell → Hold | |||
11/04/2024 | 68.47% | DA Davidson | $153 → $171 | Maintains | Neutral | |||
11/01/2024 | 36.95% | Barclays | $137 → $139 | Maintains | Underweight | |||
10/14/2024 | 36.95% | Evercore ISI Group | $140 → $139 | Maintains | Underperform | |||
10/11/2024 | 34.98% | Barclays | $130 → $137 | Maintains | Underweight | |||
10/11/2024 | 71.43% | JP Morgan | $148 → $174 | Maintains | Neutral | |||
10/01/2024 | 84.24% | Jefferies | $174 → $187 | Upgrade | Hold → Buy | |||
09/24/2024 | 52.71% | Wells Fargo | $135 → $155 | Maintains | Underweight | |||
09/06/2024 | 67.49% | Citigroup | $165 → $170 | Maintains | Neutral | |||
09/06/2024 | 50.74% | DA Davidson | $153 → $153 | Maintains | Neutral | |||
08/28/2024 | 62.56% | Citigroup | $145 → $165 | Maintains | Neutral | |||
08/05/2024 | 28.08% | Barclays | $122 → $130 | Maintains | Underweight | |||
08/02/2024 | 50.74% | DA Davidson | $162 → $153 | Maintains | Neutral | |||
08/02/2024 | 45.81% | JP Morgan | $150 → $148 | Maintains | Neutral | |||
08/02/2024 | 48.77% | Deutsche Bank | $144 → $151 | Maintains | Hold | |||
07/23/2024 | 20.2% | TD Cowen | → $122 | Initiates | → Sell | |||
07/22/2024 | 47.78% | JP Morgan | $158 → $150 | Maintains | Neutral | |||
07/19/2024 | 20.2% | Barclays | $132 → $122 | Maintains | Underweight | |||
07/10/2024 | 42.86% | Citigroup | $150 → $145 | Maintains | Neutral | |||
07/10/2024 | 28.08% | Wells Fargo | $135 → $130 | Maintains | Underweight | |||
06/24/2024 | 28.08% | Exane BNP Paribas | → $130 | Initiates | → Underperform | |||
05/02/2024 | 33% | Wells Fargo | $140 → $135 | Maintains | Underweight | |||
05/02/2024 | 30.05% | Barclays | $136 → $132 | Maintains | Underweight | |||
05/01/2024 | 47.78% | Citigroup | $155 → $150 | Maintains | Neutral | |||
05/01/2024 | 56.65% | UBS | $164 → $159 | Maintains | Neutral | |||
05/01/2024 | 55.67% | JP Morgan | $159 → $158 | Maintains | Neutral | |||
05/01/2024 | 39.9% | Evercore ISI Group | $145 → $142 | Maintains | Underperform | |||
04/17/2024 | 48.77% | Deutsche Bank | $155 → $151 | Maintains | Hold | |||
04/17/2024 | 59.61% | DA Davidson | $162 → $162 | Maintains | Neutral | |||
04/16/2024 | 52.71% | Citigroup | $165 → $155 | Maintains | Neutral | |||
04/10/2024 | 33.99% | Barclays | $148 → $136 | Maintains | Underweight | |||
04/02/2024 | 62.56% | Citigroup | $170 → $165 | Downgrade | Buy → Neutral | |||
03/26/2024 | 57.64% | Morgan Stanley | $160 → $160 | Maintains | Equal-Weight | |||
03/26/2024 | 42.86% | Jefferies | → $145 | Upgrade | Underperform → Hold | |||
03/01/2024 | 37.93% | Goldman Sachs | → $140 | Reinstates | → Sell | |||
02/05/2024 | 59.61% | DA Davidson | → $162 | Downgrade | Buy → Neutral | |||
02/02/2024 | 67.49% | UBS | $145 → $170 | Maintains | Neutral | |||
01/18/2024 | 49.75% | JP Morgan | $145 → $152 | Maintains | Neutral | |||
01/16/2024 | 16.26% | Barclays | $115 → $118 | Maintains | Underweight | |||
12/15/2023 | 47.78% | B of A Securities | $120 → $150 | Upgrade | Underperform → Neutral | |||
11/22/2023 | 42.86% | JP Morgan | $124 → $145 | Upgrade | Underweight → Neutral | |||
11/17/2023 | 59.61% | DA Davidson | $152 → $162 | Maintains | Buy | |||
11/13/2023 | 15.27% | Jefferies | → $117 | Initiates | → Underperform | |||
11/06/2023 | 30.05% | UBS | $124 → $132 | Upgrade | Sell → Neutral | |||
11/02/2023 | 47.78% | Citigroup | $135 → $150 | Upgrade | Neutral → Buy | |||
10/12/2023 | 18.23% | Bernstein | → $120 | Upgrade | Underperform → Market Perform | |||
10/11/2023 | 33% | Citigroup | $170 → $135 | Maintains | Neutral | |||
10/05/2023 | 18.23% | Evercore ISI Group | $160 → $120 | Maintains | Underperform | |||
10/05/2023 | 22.17% | JP Morgan | $152 → $124 | Maintains | Underweight | |||
10/05/2023 | 18.23% | B of A Securities | $145 → $120 | Maintains | Underperform | |||
10/05/2023 | — | Raymond James | — | Downgrade | Outperform → Market Perform | |||
10/02/2023 | 49.75% | DA Davidson | → $152 | Upgrade | Neutral → Buy | |||
09/22/2023 | 43.84% | HSBC | → $146 | Initiates | → Hold | |||
09/19/2023 | 49.75% | DA Davidson | $176 → $152 | Maintains | Neutral | |||
09/19/2023 | 37.93% | Wells Fargo | $150 → $140 | Maintains | Underweight | |||
08/07/2023 | 73.4% | DA Davidson | $155 → $176 | Maintains | Neutral | |||
08/04/2023 | 25.12% | Barclays | $117 → $127 | Maintains | Underweight | |||
08/03/2023 | — | Atlantic Equities | — | Upgrade | Underweight → Neutral | |||
07/20/2023 | 15.27% | Barclays | $124 → $117 | Maintains | Underweight | |||
07/11/2023 | 67.49% | Citigroup | → $170 | Reiterates | Neutral → Neutral | |||
05/08/2023 | 52.71% | DA Davidson | → $155 | Reiterates | → Neutral |
El último precio objetivo de Clorox (NYSE:CLX) fue comunicado por Citigroup el noviembre 4, 2025. La firma de analistas fijó un precio objetivo para $120.00 que espera CLX a rise dentro de 12 meses (un posible 18.23% upside). 39 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Clorox (NYSE:CLX) fue proporcionada por Citigroup, y Clorox mantuvo su neutral calificación.
La última revisión al alza de Clorox Co se produjo en enero 7, 2025, cuando Wells Fargo elevó su precio objetivo a $157. Wells Fargo anteriormente tenía an underweight para Clorox Co.
La última revisión a la baja de Clorox Co se produjo en abril 2, 2024, cuando Citigroup cambió su precio objetivo de $170 a $165 para Clorox Co.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Clorox, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Clorox se registró el noviembre 4, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 4, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Clorox (CLX) fue un mantuvo con un precio objetivo de $130.00 a $120.00. El precio actual al que cotiza Clorox (CLX) es de $101.50, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.